251 related articles for article (PubMed ID: 20100878)
1. Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype.
Ba BB; Arpin C; Bikie Bi Nso B; Dubois V; Saux MC; Quentin C
Antimicrob Agents Chemother; 2010 Apr; 54(4):1443-52. PubMed ID: 20100878
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
Allen GP; Bierman BC
Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
[TBL] [Abstract][Full Text] [Related]
3. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of Staphylococcus aureus and Enterococcus faecalis mutants with reduced susceptibility to the investigational oxazolidinone RWJ-416457.
Santoro CM; Bush K; Abbanat D
Int J Antimicrob Agents; 2010 Nov; 36(5):424-9. PubMed ID: 20846828
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
Andes D; van Ogtrop ML; Peng J; Craig WA
Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
[TBL] [Abstract][Full Text] [Related]
6. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
[TBL] [Abstract][Full Text] [Related]
7. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.
Lobritz M; Hutton-Thomas R; Marshall S; Rice LB
Antimicrob Agents Chemother; 2003 Oct; 47(10):3318-20. PubMed ID: 14506047
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
Livermore DM; Warner M; Mushtaq S; North S; Woodford N
Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
[TBL] [Abstract][Full Text] [Related]
10. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
[TBL] [Abstract][Full Text] [Related]
11. Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.
Qi C; Zheng X; Obias A; Scheetz MH; Malczynski M; Warren JR
J Clin Microbiol; 2006 Mar; 44(3):1098-100. PubMed ID: 16517903
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Hall AD; Steed ME; Arias CA; Murray BE; Rybak MJ
Antimicrob Agents Chemother; 2012 Jun; 56(6):3174-80. PubMed ID: 22470111
[TBL] [Abstract][Full Text] [Related]
13. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.
Prystowsky J; Siddiqui F; Chosay J; Shinabarger DL; Millichap J; Peterson LR; Noskin GA
Antimicrob Agents Chemother; 2001 Jul; 45(7):2154-6. PubMed ID: 11408243
[TBL] [Abstract][Full Text] [Related]
14. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
Firsov AA; Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Romanov AV; Edelstein MV; Zinner SH
J Antimicrob Chemother; 2017 Nov; 72(11):3100-3107. PubMed ID: 28981793
[TBL] [Abstract][Full Text] [Related]
15. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
16. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.
Marshall SH; Donskey CJ; Hutton-Thomas R; Salata RA; Rice LB
Antimicrob Agents Chemother; 2002 Oct; 46(10):3334-6. PubMed ID: 12234875
[TBL] [Abstract][Full Text] [Related]
17. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Locke JB; Hilgers M; Shaw KJ
Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
[TBL] [Abstract][Full Text] [Related]
18. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
19. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
[TBL] [Abstract][Full Text] [Related]
20. The post-antibiotic effects of linezolid against Gram-positive pathogens.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
